- Home
- EVER vs HUMA Comparison
EVER vs HUMA Comparison
Compare EVER & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVER
- HUMA
- Stock Information
- Founded
- EVER 2008
- HUMA 2004
- Country
- EVER United States
- HUMA United States
- Employees
- EVER N/A
- HUMA N/A
- Industry
- EVER Computer Software: Programming Data Processing
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- EVER Technology
- HUMA Health Care
- Exchange
- EVER Nasdaq
- HUMA Nasdaq
- Market Cap
- EVER 735.7M
- HUMA 584.8M
- IPO Year
- EVER 2018
- HUMA N/A
- Fundamental
- Price
- EVER $21.63
- HUMA $4.37
- Analyst Decision
- EVER Strong Buy
- HUMA Strong Buy
- Analyst Count
- EVER 6
- HUMA 7
- Target Price
- EVER $31.67
- HUMA $13.43
- AVG Volume (30 Days)
- EVER 446.9K
- HUMA 2.4M
- Earning Date
- EVER 02-24-2025
- HUMA 03-21-2025
- Dividend Yield
- EVER N/A
- HUMA N/A
- EPS Growth
- EVER N/A
- HUMA N/A
- EPS
- EVER 0.38
- HUMA N/A
- Revenue
- EVER $408,440,000.00
- HUMA N/A
- Revenue This Year
- EVER $72.34
- HUMA N/A
- Revenue Next Year
- EVER $18.98
- HUMA $4,344.68
- P/E Ratio
- EVER $57.53
- HUMA N/A
- Revenue Growth
- EVER 27.43
- HUMA N/A
- 52 Week Low
- EVER $13.07
- HUMA $2.81
- 52 Week High
- EVER $28.09
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- EVER 64.61
- HUMA 45.11
- Support Level
- EVER $19.28
- HUMA $4.20
- Resistance Level
- EVER $21.41
- HUMA $4.78
- Average True Range (ATR)
- EVER 0.97
- HUMA 0.28
- MACD
- EVER 0.25
- HUMA -0.02
- Stochastic Oscillator
- EVER 98.85
- HUMA 42.17
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.